# A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss

> **NCT05910450** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Cassiopea SpA** · enrollment: 703 (actual)

## Conditions studied

- Alopecia, Androgenetic

## Interventions

- **DRUG:** Clascoterone 5% solution
- **DRUG:** Vehicle solution

## Key facts

- **NCT ID:** NCT05910450
- **Lead sponsor:** Cassiopea SpA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-06-21
- **Primary completion:** 2026-01-26
- **Final completion:** 2026-06
- **Target enrollment:** 703 (ACTUAL)
- **Last updated:** 2026-03-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05910450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05910450, "A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05910450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*